Skip to main content

Table 3 Postoperative recipient-related data

From: Impact of patent foramen ovale on short-term outcomes in children with biliary atresia undergoing living donor liver transplantation: a retrospective cohort study

Variable

PFO (n = 73)

NoPFO (n = 231)

P-Value

Ventilation time (min)

184(151–286)

220(133–352)

0.533

Postoperative ICU stay (d)

3.0(2.0–3.0)

2.5(2.0–3.0)

0.267

Postoperative hospital stay (d)

22(18–27)

21(16–27)

0.138

AKI (%)

14(19.2%)

57(24.7%)

0.333

Graft dysfunction (%)

8(11.0%)

29(12.6%)

0.716

HAT (%)

4(5.5%)

11(4.8%)

0.762

PVT (%)

2(2.7%)

5(2.2%)

0.675

Liver function test during the first 5 days after LDLT

Peak ALT (U/L)

623(450–1142)

585(384–1082)

0.281

Peak AST (U/L)

700(538–1410)

692(466–1194)

0.192

Peak Total Bilirubin (µmol/L)

87(60–114)

83(56–121)

0.73

One-year survival rate (%)

69(94.5%)

221(95.7%)

0.929

  1. ICU, intensive care unit; AKI, acute kidney injury; HAT, hepatic artery thrombosis; PVT, portal vein thrombosis; ALT, alanine aminotransferase; AST, aspartate aminotransferase